AstraZeneca Leads at ASCO Day 3 Amidst Takeda and Lilly Updates

TL;DR
At ASCO Day 3, AstraZeneca showcased its dominance, Takeda revealed data on an experimental drug, and Eli Lilly served a salad at its booth, highlighting the event's mix of scientific updates and marketing strategies.
Topics:businesshealth-and-medicine#asco#astrazeneca#cancer-research#eli-lilly#health-and-medicine#takeda
Want the full story? Read the original reporting
Read on statnews.com